Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Wave Life Sci Ord Sh (NQ: WVE )

4.340 USD -0.050 (-1.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 148,067
Open 4.420
Bid (Size) 3.900 (7)
Ask (Size) 4.350 (20)
Prev. Close 4.390
Today's Range 4.160 - 4.433
52wk Range 4.160 - 12.17
Shares Outstanding 50,766,062
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a Clinical Trial of WVE-N531 in Duchenne Muscular Dystrophy
From GlobeNewswire News Releases
Wave Life Sciences Announces New Data for Leading RNA Editing Capability Across Multiple Tissues and Provides Update on AATD Program During Analyst and Investor Research Webcast
From GlobeNewswire News Releases

Performance

YTD
-47.65%
-47.65%
1 Month
-28.62%
-28.62%
3 Month
-20.80%
-20.80%
6 Month
-30.78%
-30.78%
1 Year
-45.68%
-45.68%

More News

Read More
Wave Life Sciences to Present at the Chardan Virtual Genetic Medicines Conference
From GlobeNewswire News Releases
Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a SELECT-HD Clinical Trial of WVE-003 in Huntington’s Disease
From GlobeNewswire News Releases
Wave Life Sciences to Highlight RNA Editing Capability and AATD and Neurology Programs at 2021 Analyst and Investor Research Webcast on September 28, 2021
From GlobeNewswire News Releases
Wave Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
From GlobeNewswire News Releases
Wave Life Sciences to Highlight RNA Editing Modality and PRISM Platform Advancements During Upcoming Scientific Conferences
From GlobeNewswire News Releases
Wave Life Sciences Reports Second Quarter 2021 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Wave Life Sciences, Takeda Discontinue Research On Preclinical CNS Programs
Tags Biotech Preclinical Phase Trading Ideas
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Tags IDRA MDGS AVCO
From Benzinga
Analysts Forecast 21% Upside For IEIH
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]